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Sensitivity of human pluripotent 
stem cells to insulin precipitation 
induced by peristaltic pump-based 
medium circulation: considerations 
on process development
Diana Massai1,2, Emiliano Bolesani1,2, Diana Robles Diaz1,2, Christina Kropp1,2, Henning 
Kempf1,2, Caroline Halloin1,2, Ulrich Martin1,2, Tudor Braniste1,3, Giuseppe Isu4,5, Vanessa 
Harms6, Umberto Morbiducci4, Gerald Dräger2,6 & Robert Zweigerdt1,2
Controlled large-scale production of human pluripotent stem cells (hPSCs) is indispensable for their 
envisioned clinical translation. Aiming at advanced process development in suspension culture, 
the sensitivity of hPSC media to continuous peristaltic pump-based circulation, a well-established 
technology extensively used in hydraulically-driven bioreactors, was investigated. Unexpectedly, 
conditioning of low protein media (i.e. E8 and TeSR-E8) in a peristaltic pump circuit induced severe 
viability loss of hPSCs cultured as aggregates in suspension. Optical, biochemical, and cytological 
analyses of the media revealed that the applied circulation mode resulted in the reduction of the growth 
hormone insulin by precipitation of micro-sized particles. Notably, in contrast to insulin depletion, 
individual withdrawal of other medium protein components (i.e. bFGF, TGFβ1 or transferrin) provoked 
minor reduction of hPSC viability, if any. Supplementation of the surfactant glycerol or the use of the 
insulin analogue Aspart did not overcome the issue of insulin precipitation. In contrast, the presence 
of bovine or human serum albumin (BSA or HSA, respectively) stabilized insulin rescuing its content, 
possibly by acting as molecular chaperone-like protein, ultimately supporting hPSC maintenance. 
This study highlights the potential and the requirement of media optimization for automated hPSC 
processing and has broad implications on media development and bioreactor-based technologies.
Human pluripotent stem cells (hPSCs), due to their essentially unlimited proliferative capacity and their poten-
tial to differentiate into any somatic cell type in vitro, represent a superior cell source for biomedical sciences1, 2. 
In the perspective of their clinical and industrial applications, it was recently shown that hPSCs, including human 
embryonic (hESCs) and human induced pluripotent (hiPSCs) cells, can be cultivated as “matrix-free cell only 
aggregates” in static and dynamic suspension culture3–5. This approach eliminates matrix requirements, enables 
transition from surface-dependent two-dimensional (2D) culture towards three-dimensional (3D) cultivation, 
and supports development and up-scaling of good manufacturing practice (GMP)-compliant processes2, 6–9. 
However, recent studies revealed that the 2D-to-3D switch induces distinct molecular changes in hPSCs such 
as the differential cleavage of E-cadherin, thereby modulating cell-cell communication and the activity of spe-
cific pathways, particularly WNT signaling10. Moreover, high sensitivity of hPSCs to physicochemical culture 
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parameters in suspension has been demonstrated6, 11, 12. For instance, turbulent hydrodynamic conditions and 
subsequent shear stresses in stirred culture vessels can markedly affect hPSC aggregates by reducing cell via-
bility and disrupting the sensitive equilibrium of pluripotency versus differentiation, and can lead to undesired 
culture heterogeneity9, 13, 14. Thus, for the successful hPSC processing in bioreactors, several parameters includ-
ing bioreactor design (e.g. vessel shape, dimensions, geometry and the arrangement of impellers, probes, ports, 
etc.) and working conditions (e.g. agitation speed, working volume, etc.) must be considered9, 13, 15, 16. Further 
process-determining factors comprise culture media composition and stability17, 18. Since their initial use for 
hESC culture19, growth media for hPSC culture have undergone a continuous evolution with the ultimate goal 
to develop serum-free, xeno-free, and chemically defined formulations suitable for therapeutic application18. In 
addition, the complex interplay of environmental parameters, namely dissolved oxygen concentration (DO), pH, 
cell density, cell feeding strategies, and others, should be considered6, 20, 21.
Consequently, increasing efforts were dedicated to the development of universal, controlled and predictive hPSC 
mass production strategies22, particularly in industry-compliant instrumented stirred-tank bioreactors6, 8, 9, 18, 23, 24. 
Indeed, applying “matrix-free cell only aggregate” culture in the complex medium mTeSR115 or in the chemically 
defined xeno-free medium E817 in combination with single-use stirred-tank bioreactors21 led to encouraging 
progress9, 24.
However, linear - rather than aspired exponential - growth kinetics of hPSCs were achieved in impeller 
stirred-tank bioreactors15, 21. Additionally, aggregate size heterogeneity, which might impact on subsequent dif-
ferentiation results25, 26, was described in several stirred culture platforms5, 9, 13, 14, 24. This suggests that numerous 
limitations still exist, triggering investigations into alternative culture technologies.
Recently, an impeller-free bioreactor for dynamic suspension culture was proposed27. The system exploits 
laminar hydrodynamics. Thanks to an appositely designed vessel geometry and the connection to a circulation 
circuit, buoyant vortices form within the culture chamber allowing homogeneous distribution of cells/aggregates 
in suspension at low-shear conditions27. Medium flow in this system is achieved by peristaltic pump technology28, 
which is extensively used in a broad range of hydraulically driven bioreactors requiring continuous medium 
circulation29–32.
In order to test the applicability of this platform for suspension culture of hPSCs, this study investigated how 
specific hPSC expansion media (i.e. E8, TeSR-E8, mTeSR1 and StemMACS iPS-Brew XF) comply with continuous 
peristaltic pump-based circulation. The findings revealed an unexpected sensitivity of specific media components 
to the applied circulation mode. In particular, in low protein media E8 and TeSR-E8, peristaltic pumping induced 
physical instability of the growth hormone insulin which precipitated in insoluble particles. Relevant bioassays, 
based on hiPSC and hESC lines, revealed unreported sensitivity of hPSCs to reduced insulin concentrations. 
In contrast, sequential omission of other factors that are known to be essential for maintaining hPSC pluripo-
tency, including bFGF or TGFβ117, 18, showed minor short term effects on cell viability and the integrity of hPSC 
aggregates. Notably, in the presence of bovine or human serum albumin (BSA or HSA, respectively), detrimental 
effects on hPSCs were limited despite the peristaltic pump conditioning of respective media, suggesting that albu-
min stabilizes dissolved insulin in hPSC media. While the physical instability of insulin in solution is well known 
in the diabetes research and industrial field33–35, inadequate attention to this subject has been dedicated in hPSC 
culture media development.
Due to the necessity of the hPSC field to move towards GMP-compliant, chemically defined low protein media 
compositions2, 9, 36 and the extensive use of peristaltic pumps in bioprocessing37, this study has substantial impact 
within and beyond hPSC manufacturing.
Results
Disruption of hPSC aggregate culture by peristaltic pump conditioned E8 was mediated by 
insulin depletion. Respective hiPSC and hESC aggregates pre-formed by established, single cell-inoculated 
suspension (Fig. 1a)3, 5 were cultured in hPSC media conditioned by treatments schematically depicted in Fig. 1b. 
In static conditioned E8 medium (SC E8), hPSC aggregates maintained their spherical morphology and increased 
in diameter over the 3 days assessed (Fig. 2a–c for hiPSCs and Fig. 2g–i for hESCs), according to published 
data3–5. Unexpectedly, light microscopy images of hPSC aggregates cultured in peristaltic pump conditioned E8 
medium (PC E8) showed floating single cells and hPSC aggregates with irregular morphology and reduced size 
compared to the respective SC E8 controls already after one day of cultivation, followed by increase in cell debris 
and disaggregation on days 2–3 (Fig. 2d–f for hiPSCs and Fig. 2j–l for hESCs).
In search for the underlying mechanism, E8 medium was individually conditioned with all physical com-
ponents of the peristaltic circuit in direct contact with the medium (i.e. tubing, connections, and the medium 
reservoir). None of these conditioned media induced detrimental effects on hPSC aggregates (data not shown), 
confirming cytocompatibility of all components used in the system.
Notably, light microscopy of SC E8 (Fig. 3a and b) and PC E8 (Fig. 3d and e) revealed the presence of irregular 
particles of up to ~50 µm in size in PC E8, only. Extensive sterility tests excluded microbial contamination of any 
native or conditioned medium tested throughout the study (data not shown). To investigate the potential pres-
ence of dust or release of debris and degradation material, e.g. due to spallation of the tubing, deionized water or 
DMEM/F12 (Fig. 3c), the basic medium for E8 lacking any supplementation of E8-specific proteins, were condi-
tioned within the peristaltic circuit. This analysis did not indicate any release of particles from the applied circuit 
components (Fig. 3f), rather it suggested a relationship between protein components in E8 and the formation of 
the aforementioned particles in combination with peristaltic pump conditioning.
To test this hypothesis, E8 lacking one protein at a time (i.e. E8 minus bFGF, -TGFβ1, -transferrin, -insulin) 
was conditioned by static and peristaltic pump treatment, respectively. Light microscopy revealed that no parti-
cles were detectable in any SC medium (Fig. 3g–j), as expected. In contrast, applying peristaltic pump condition-
ing resulted in substantial particle formation in all media (Fig. 3k–m), except in the absence of insulin (Fig. 3n).
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Moreover, semi-quantitative UPLC-MS analysis of SC E8 and PC E8 media samples revealed that less than 
10% of dissolved insulin was present in PC E8 compared to SC E8 controls (Fig. 3o). Together, this strongly 
suggested that the insulin in E8 was underlying the formation of particle-like precipitates induced by peristaltic 
pump-based circulation, as confirmed by particle solubilization (Supplementary Figures S1 and S2). In conse-
quence, dissolved insulin was almost entirely depleted within 12 h.
To further correlate the physicochemical results with biological effects, hiPSC aggregates were cultured in 
SC E8 (control) and PC E8 lacking one protein at a time (omitted before initiation of conditioning, Fig. 4a–p). 
Interestingly, in SC E8 omission of either bFGF, TGFβ1 or transferrin had only minor effects on hiPSC aggregate 
morphology monitored for up to 3 days (Fig. 4a–c and e–g). In contrast, omitting insulin resulted in apparent 
shading of hiPSC aggregates readily after 24 h and progressive shrinkage thereafter (Fig. 4d and h). The mor-
phological analysis was complemented by propidium iodide (PI)-based flow cytometry, revealing that the lack 
of either bFGF, TGFβ1, or transferrin induced 4.5% to 6.3% of PI-positive (i.e. dead) cells comparable to 6.0% 
observed in SC E8 controls (Fig. 4q). In contrast, in the absence of insulin, the percentage of dead cells reached 
39.6% (Fig. 4q). This highlights the absolute necessity of insulin for hPSC integrity, at least for the applied culture 
conditions. On the other hand, omission of any other factor, including bFGF and TGFβ1 known to be essential for 
long-term maintenance of hPSCs17, 38, 39, was unremarkable in this short-term assay. This was further confirmed 
by the flow cytometry analysis of pluripotency-associated markers NANOG and OCT4, revealing minor differ-
ences in hiPSC aggregates cultured for 3 days in SC E8 versus SC E8 lacking one protein at a time (Fig. 4r and s), 
in accordance to literature17, 40, 41. However, combining the omission of specific media components before condi-
tioning with peristaltic treatment induced much more drastic effects (Fig. 4i–p). Since peristaltic pump treatment 
depleted dissolved insulin from E8 (as demonstrated above by UPLC-MS investigation; Fig. 3o), the omission 
of bFGF, TGFβ1 or transferrin ahead of the conditioning process was now complemented with the PC-induced 
insulin loss. In consequence, presumptive lack of two factors provoked pronounced cell-disaggregation readily 
after 24 h of cultivation (Fig. 4i–k), further progressing towards aggregate disruption on day 3 (Fig. 4m–o). This 
was particularly evident when insulin and bFGF, both critical for hPSC survival38, were missing (Fig. 4i and m).
In contrast, omitting insulin ahead of peristaltic pump treatment essentially reflected the respective static 
conditioning (as shown in Fig. 4l and p versus Fig. 4d and h, respectively). This observation tallied with the idea 
that if insulin is not added to E8 beforehand any subsequent conditioning has a minor effect, if any, on media 
composition.
Figure 1. hPSC aggregate suspension culture and hPSC culture media conditioning. (a) Schematic of hPSC 
aggregate culture set-up including representative light microscopy pictures. Single hPSCs were inoculated 
(d-1) and positioned for aggregate formation on an orbital shaker for 24 h. hPSC aggregates formed at d0 were 
harvested and cultured with conditioned media on an orbital shaker for further 72 h. Optical assessment was 
performed daily, with flow cytometry analysis on d1 and d3. (b) Schematic of hPSC culture media conditioning 
set-up including static conditioning in 50 mL tube (SC), continuous circulation within a closed-loop peristaltic 
pump-based circuit (PC), and continuous circulation within a chandler loop system (CC).
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As additional control experiment, insulin was retrospectively supplemented to PC E8 medium, which there-
fore contained precipitated particles. Notably, the resulting medium regained ability to support hiPSC aggregate 
cultivation (Fig. 4t and u). This experiment underscored that the biological effects described herein were mainly 
induced by the depletion of insulin, whereas the presence of particle-like precipitates did not show obvious 
toxicity.
Figure 2. hPSC aggregates cultured in suspension with SC E8 and PC E8. Light microscopy images showed that 
(a–c) hiPSC and (g–i) hESC aggregates cultured in SC E8 maintained their spherical morphology and increased 
in diameter over the 3 days. In contrast, light microscopy images of (d–f) hiPSC and (j–l) hESC aggregates 
cultured in PC E8 showed floating single cells and aggregates with irregular morphology already on d1, followed 
by an increase in cell debris and disaggregation on d2–3. Scale bar = 100 µm.
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Physical mechanisms occurring within and on the peristaltic pump-compressed tubing induced 
insulin precipitation. To investigate the mechanisms underlying insulin precipitation, E8 medium was 
tested at different flow rates within the peristaltic pump circuit, and by combining an alternative circulation 
set-up with different tubing formulations.
Flow rates of 5, 50 or 100 mL/min were tested for 12 h. Light microscopy images of PC E8 and consecutively 
cultured hiPSC aggregates showed slight differences depending on the applied flow rate, but the critical effect of 
peristaltic pumping was evident and comparable for all tested conditions (Supplementary Figure S3).
To independently investigate the medium-tubing interplay (by comparing two different tubing formulations, 
i.e. Platinum-cured silicone versus Tygon) and the role of mechanical stresses arising from tubing compression by 
the pump, a comparison between peristaltic (PC)- and chandler loop (CC)-based conditioning (see schematic in 
Fig. 1b) was performed applying the same flow rate. For both tested tubing formulations, no particles formed in 
CC E8 (Supplementary Figure S4a,b) and, on day 3, normal morphology and size distribution of cell aggregates 
equivalent to SC E8 controls were observed (Supplementary Figure S4e,f versus Fig. 2c). In contrast, precipitated 
Figure 3. Optical inspection of conditioned media. Light microscopy images of SC E8 at (a) 10x (scale 
bar = 100 µm) and (b) 40x magnification (scale bar = 10 µm) revealed a transparent medium, whereas in 
(d–e) PC E8 the presence of irregular particles of up to ~50 µm was observed. The (c) static and (f) peristaltic 
pump conditioning of DMEM/F12 did not indicate any release of particles from circuit components (scale 
bar = 10 µm). Similarly, (g–j) no particles were detectable in any SC E8 media lacking one protein at a time 
omitted before conditioning (scale bar = 10 µm). In contrast, peristaltic pump conditioning resulted in 
substantial particle formation in (k) E8 minus bFGF, (l) E8 minus TGFβ1, and (m) E8 minus transferrin, except 
in (n) E8 minus insulin (scale bar = 10 µm). (o) Semi-quantitative UPLC-MS analysis of SC E8 and PC E8 media 
revealed that less than 10% of dissolved insulin remained in PC E8 compared to SC E8 controls (n = 2).
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Figure 4. hiPSC aggregates cultured in suspension with SC E8 and PC E8 lacking one protein at a time 
omitted before conditioning. Light microscopy images of hiPSC aggregates, on day 1 and day 3, cultured in 
SC E8 lacking one protein at a time, omitted before conditioning, showed that omission of either (a,e) bFGF, 
(b,f) TGFβ1 or (c,g) transferrin had only minor effects on hiPSC aggregate morphology. In contrast, omitting 
insulin resulted in (d) apparent shading of hiPSC aggregates readily after 24 h and (h) progressive shrinkage 
thereafter. Light microscopy images of hiPSC aggregates cultured with PC E8 lacking one protein at a time 
showed that (i–k) lack of bFGF, TGFβ1 or transferrin, omitted before conditioning, combined with PC-induced 
insulin loss elicited pronounced cell-disaggregation readily after 24 h of cultivation, (m–o) further progressing 
towards aggregate disruption on day 3, particularly when (i,m) insulin and bFGF were missing. In contrast, 
(l,p) omitting insulin ahead of PC reflected the respective (d,h) SC condition. (q) PI-based flow cytometry, 
performed for quantitative assessment of viability of day 3 hiPSC aggregates cultured in SC E8 lacking either 
bFGF, TGFβ1 or transferrin, showed dying PI-positive cells ranging from 4.5% to 6.3%, comparable to the 6.0% 
of the SC E8 control, while in the absence of insulin almost a 40% of dead cells was reached. Flow cytometry 
based on the pluripotency-associated markers (r) NANOG and (s) OCT4 performed on day 3 hiPSC aggregates 
revealed minor differences in marker expressions among hiPSC aggregates cultured with SC E8 and SC E8 
lacking one protein at a time. (t,u) Insulin retrospectively supplemented to PC E8 medium allowed to support 
hiPSC aggregate cultivation. Scale bar = 100 µm.
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particles were detected within the PC E8 for both tubing types (Supplementary Figure S4c,d) and detrimental 
biological effects on hiPSC aggregates were found at day 3 (exemplary depicted in Supplementary Figure S4g,h). 
Scanning electron microscope (SEM) images of the tubing lumen (Supplementary Figure 5) showed the effect of 
the peristaltic pump on the tubing. Tubing sections collected from regions outside the pump head were smooth 
and homogeneous at their internal surface (Supplementary Figure 5a–c). In contrast, amorphous agglomerates 
attached to the tubing lumen were detected in samples from the pump head region (Supplementary Figure 5d–f) 
and identified as silicone debris (Supplementary Figure S6), showing that continuous cyclic compression caused 
local tubing abrasion. These results suggested that insulin precipitation was promoted by the combination of 
hydrodynamic and mechanical forces acting within and on the tubing segment located in the peristaltic pump 
head, and the interfacial interaction of the media with the hydrophobic inner surface of the tubing, characterized 
by increased roughness due to wear.
Insulin depletion and hPSC viability were rescued by HSA supplementation. Inspired by the pharma-
cological strategies based on excipients targeted to maximize stability of dissolved proteins, the following approaches 
were tested (Fig. 5): (1) addition of glycerol42, 43; (2) replacement of insulin commonly used for culture media formula-
tion with the analogue insulin Aspart44, 45; (3) supplementation of human serum albumin (HSA)33, 46, 47.
Reflecting published studies43, 48, glycerol was added at 1, 5, or 10 g/L to E8 before conditioning; data shown 
for 5 g/L glycerol are representative for this assay. The resulting SC medium (E8 + 5 g/L Glycerol) appeared trans-
parent (Fig. 5a) and glycerol addition did not affect the hiPSC aggregate culture (Fig. 5g). However, glycerol at any 
tested concentration did neither prevent PC-induced insulin precipitation (Fig. 5d), nor enabled hiPSC aggregate 
culture (Fig. 5j).
Next, the engineered insulin Aspart, approved for therapeutic use, was used for conventional insulin replace-
ment (E8 Aspart). SC E8 Aspart (Fig. 5b) fully supported hiPSC aggregate culture (Fig. 5h). However, after peri-
staltic pump conditioning typical microscopic particles were detected (Fig. 5e) and the medium disrupted hiPSC 
aggregates cultivation (Fig. 5k).
Finally, HSA at 0.01%, 0.1%, or 1% was added to E8 before conditioning. The SC E8 + 0.1% HSA was trans-
parent (Fig. 5c) and suitable for hiPSC (Fig. 5i) and hESC (Fig. 5m) aggregate culture. Surprisingly, although 
particle formation was detectable in the peristaltic conditioned medium (Fig. 5f), PC E8 + 0.1% HSA efficiently 
supported hiPSC (Fig. 5l) and hESC (Fig. 5n) propagation in suspension. A similar outcome but at lower efficacy 
was observed for hiPSC aggregates cultured with E8 + 0.01% HSA (Supplementary Figure S7e,g), while at higher 
concentration of 1% HSA detrimental effects on hiPSC aggregates for both static and peristaltic conditioning 
were observed (Supplementary Figure S7f,h).
Analysis by UPLC-MS (Fig. 6) revealed maintenance of high dissolved insulin content in PC E8 + 0.1% HSA 
(around 80%) compared to SC E8 and in contrast to the PC E8 (7.5%), while dissolved insulin was slightly pre-
served in PC E8 + 0.01% HSA (>33% of insulin remaining). Together, this supported the view that (1) insulin 
availability is the key factor for hiPSC survival in the adopted assay, and (2) HSA is beneficial for insulin preser-
vation and stabilization.
Quantitative assessment of hPSC viability by PI-based flow cytometry revealed, on day 1, a dead cell content 
of 16% for hiPSC (Fig. 7g) and ~33% for hESC (Fig. 7q) aggregates cultured in PC E8, while for SC E8 controls 
values of ~2% for hiPSCs (Fig. 7a) and ~10% for hESCs (Fig. 7m) were found. On day 3, ~57% PI-positive cells 
for hiPSC (Fig. 7j) and ~65% for hESC (Fig. 7s) aggregates were discovered, representing a drastic loss of viability 
compared to 4–6% for respective hiPSC (Fig. 7d) and hESC (Fig. 7o) controls cultured in SC E8. Moreover, this 
assay confirmed that the presence of HSA substantially limited the percentage of PI-positive cells for both hPSC 
aggregates, e.g. on day 3 cell death was limited to ~7–8% for hiPSCs (Fig. 7k and l) and ~9% for hESCs (Fig. 7t), 
in accordance with the qualitative assessment of aggregates by light microscopy (Supplementary Figure S7g and 
Fig. 5l and n).
Finally, pluripotency assessment of day 3 hPSC aggregates revealed that more than 90% of cells expressed 
NANOG (Fig. 7aa–ae for hiPSCs and Fig. 7af–ah for hESCs) and OCT4 (Fig. 7ai–am for hiPSCs and Fig. 7an–ap 
for hESCs) with negligible differences among SC E8 with/without HSA and PC E8 + HSA (Fig. 7). This further 
suggested that HSA did not affect maintenance of pluripotency.
Commercial high protein media supported hiPSC viability upon peristaltic pump condition-
ing. To ensure general validity of the presented results (beyond self-made production of E8), three commercial 
media for hPSC maintenance were tested.
TeSR-E849, a low protein medium based on E8, supported hiPSC aggregate culture when statically conditioned 
(Fig. 8g), as expected, but peristaltic pump conditioning induced particle precipitation (Fig. 8d) and loss of aggre-
gate integrity (Fig. 8j).
Peristaltic conditioning of high protein media mTeSR1 (BSA supplemented50) and StemMACS iPS-Brew XF 
induced noticeable micro-particle precipitation as well (Fig. 8e and f, respectively), but still supported hiPSC 
aggregate culture (Fig. 8k and l, respectively). However, hiPSC aggregates cultured in SC and PC mTeSR1 
were more heterogeneous in size compared to SC E8 control (Fig. 8h and k versus Fig. 2c, and Supplementary 
Figure S8), while in PC StemMACS iPS-Brew XF a considerably elevated amount of precipitated particles became 
obvious (Fig. 8l) compared to PC E8 + 0.1% HSA controls (Fig. 5l).
Discussion
In this study, specific hPSC media broadly adopted for hPSC suspension culture3, 4, 17, 21, 49 were tested for continu-
ous peristaltic pump-based circulation. Peristaltic pumping is a key technology extensively applied for perfusion 
and hydraulically-driven bioreactors since it enables closed systems with no risk of contamination by air or the 
direct contact with pump components29–32. The ultimate aim of this study was to assess compliance of hPSC 
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media with a recently published peristaltic pump-based, impeller-free suspension bioreactor27 in the perspective 
of future hPSC culture.
The investigations revealed that hPSC media are sensitive to the adopted operating conditions. In particular, 
when the low protein media E8 and TeSR-E8 were circulated in a peristaltic pump circuit, precipitation of insol-
uble particles (Figs 3c,d and 8d) and a marked insulin depletion were observed (Fig. 3o). The drastic reduction 
of soluble insulin induced a severe viability loss in day 3 hPSC aggregates cultured in suspension serving as a 
relevant reference assay (Figs 2d–f,j–l, 7g,j,q,s and 8j). Notably, the addition or the presence of bovine or human 
Figure 5. hPSC aggregates cultured in suspension with SC E8 and PC E8 supplemented with glycerol, Aspart 
or HSA. Light microscopy images of (a) SC E8 + 5 g/L Glycerol, (b) SC E8 Aspart, and (c) SC E8 + 0.1% 
HSA showed transparent media that (g–i) did not affect the hiPSC aggregate culture, similarly to (m) hESC 
aggregates cultured with SC E8 + 0.1% HSA. In contrast, (d) PC E8 + 5 g/L Glycerol, (e) PC E8 Aspart, and 
(f) PC E8 + 0.1% HSA did not prevent particle precipitation, and neither (j) glycerol nor (k) Aspart were 
able to maintain hiPSC culture. However, the addition of HSA efficiently supported (l) hiPSC and (n) hESC 
propagation in suspension. Scale bar = 100 µm.
www.nature.com/scientificreports/
9Scientific RepoRts | 7: 3950  | DOI:10.1038/s41598-017-04158-x
serum albumin in the hPSC media (i.e. E8 + HSA, mTeSR1 and StemMACS iPS-Brew XF) did not prevent the 
precipitation of particles upon peristaltic pumping (Figs 5f, 8e and f), but rescued soluble insulin (see Fig. 6 for 
E8 + HSA), ultimately aiding hPSC culture (Figs 5l,n, 7l,t and 8k and l).
Due to its extensive therapeutic use for diabetic patients, insulin is one of the most widely studied molecules in 
biochemistry. Its tendency to undergo structural transformation resulting in the formation of insoluble particles 
when exposed to physicochemical stresses, also called insulin self-association or fibrillation, is well-known in 
pharmaceutical research and industry33, 51. Insulin precipitation can lead to a drastic reduction in its biological 
and therapeutic potency, representing a critical issue during pharmaceutical processing, transport, storage, and 
clinical administration through delivery devices52–55.
Even though the exact mechanism of insulin fibrillation is still not fully understood, it is clear that it occurs 
through a series of sequential physical and/or chemical degradation pathways35, 54, leading to the formation of 
biologically inactive particles33, 51. In detail, the initial step in aggregation is probably the formation of monomeric 
molecules characterized by exposed hydrophobic faces, normally buried in the 3D structure35, 51, 52. The resulting 
non-native insulin molecules are prone to mutual interaction, with a high probability to form amorphous parti-
cles or organized fibrils that ultimately compromise the safety and efficacy of the protein33, 35, 51.
Different physicochemical factors (e.g. temperature, motion, mechanical stress, interaction with hydropho-
bic surfaces, metal ions, pH, etc.) have been identified to promote insulin precipitation33, 51, 53, 56. Particularly, in 
delivery devices (e.g. artificial pancreas or portable/implantable infusion pumps) or during production processes 
(e.g. ultrafiltration, diafiltration, etc.) the combination of fluid mechanics forces, interaction with hydrophobic 
surfaces, and heat can promote insulin fibrillation54, 55.
Though insulin fibrillation has been extensively investigated in pharmacological research, to the best of 
our knowledge, this is the first study providing evidence that continuous peristaltic pump-based circulation of 
low protein hPSC expansion media provokes insulin precipitation and depletion and consequently induces severe 
hPSC culture failure.
In recent years, increasing effort has been dedicated to identify the optimal hPSC culture conditions for defin-
ing robust chemically defined systems, and several media based on signal proteins and growth factors (e.g. insu-
lin, transferrin, albumin, bFGF, TGFβ1, Wnt, IGF), lipids, vitamins and additives were proposed17, 18, 50, 57–61. On 
the one hand, it is known that the self-renewal of hESCs requires insulin-like growth factor-1 (IGF-1) receptor 
signaling59 and that IGF-II has a central regulatory role in mammalian pre-implantation and embryonic devel-
opment62 with high sensitivity of human neural stem cells and neurons to insulin concentration63. On the other 
hand, to the best of our knowledge, no in-depth investigation on the specific role and concentration requirements 
of insulin for hPSC viability and proliferation is yet available, requesting further attention. This may include the 
parallel analysis of other media components, particularly regarding the interplay of the insulin-to-glucose ratio 
and its impact on the hPSC metabolism. Recently an adaptive, process-dependent flexibility of the hPSC metabo-
lism at the pluripotent state was reported21, and metabolic changes (i.e. glycolysis vs. oxidative phosphorylation) 
during hPSC differentiation and somatic cell reprograming into hiPSC are well established64, 65. The known inhib-
itory role of insulin, for example, during cardiac mesoderm induction of hPSCs66, 67 and the effects on viability at 
the pluripotent state shown in this study strongly mandate process-dependent adaptation and monitoring of the 
insulin concentration in the future.
In accordance with previous studies on insulin aggregation mechanisms in agitated aqueous solutions54, 68–70, 
findings in this study demonstrate that the underlying mechanisms inducing insulin fibrillation include: (1) 
hydrodynamic and mechanical forces acting within and on the tubing located in the peristaltic pump head, in 
combination with (2) the interaction of the media with the hydrophobic surface of the tubing lumen, possi-
bly catalyzed by (3) its increased roughness, as a consequence of tubing wear caused by the cyclic compres-
sion. Technically, the medium flows through flexible tubing which, in the peristaltic pump region, is fitted into a 
Figure 6. UPLC-MS analysis of SC E8 and PC E8 supplemented with HSA. The UPLC-MS analysis performed 
on samples of SC and PC E8, E8 + 0.01% HSA and E8 + 0.1% HSA revealed maintenance of high dissolved 
insulin content in PC E8 + 0.1% HSA (around 80%) compared to SC E8 controls and in contrast to PC E8 
(7.5%), while dissolved insulin was slightly preserved in PC E8 + 0.01% HSA (>33% of insulin remaining) 
(n = 2).
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Figure 7. Viability and pluripotency of hPSC aggregates cultured in suspension with SC E8 and PC E8 
supplemented with HSA. PI-based flow cytometry was performed on day 1 and day 3 for quantitative 
assessment of viability of hiPSC aggregates cultured with (a–f) SC and (g–l) PC E8, E8 + 0.01% HSA and 
E8 + 0.1% HSA, and of hESC aggregates cultured with (m–p) SC and (q–t) PC E8 and E8 + 0.1% HSA. A dead 
cell content of (g) 16% for hiPSC aggregates and (q) ~33% for hESC aggregates cultured in PC E8 was measured 
at day 1, reaching (j) ~60% and (s) ~65% on day 3, respectively, which is a drastic loss of viability compared 
to (a,d, and m,o, respectively) SC E8 controls. The presence of HSA substantially limited the percentage of 
dying PI-positive cells for (h,i,k, and l) hiPSC aggregates and for (r,t) hESC aggregates, in accordance with the 
qualitative assessment by light microscopy. Pluripotency assessment of day 3 hPSC aggregates revealed that 
more than 90% of cells expressed pluripotency-associated transcription factors NANOG for (aa–ae) hiPSCs and 
for (af–ah) hESCs and OCT4 for (ai–am) hiPSCs and for (an–ap) hESCs, confirming that HSA did not affect 
maintenance of pluripotency.
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circular casing where rollers, connected to a rotating rotor, cyclically compress it. The portion under compression 
is occluded, forcing the fluid to cyclically undergo high pressures and shear stresses and to move ahead through 
the tubing28. Moreover, local heating might result from the locally-induced turbulent kinetic energy dissipation 
Figure 8. hiPSC aggregates cultured in suspension with SC and PC commercial media. Light microscopy 
images of (a) SC TeSR-E8, (b) SC mTeSR1, and (c) SC StemMACS iPS-Brew XF showed transparent media, 
while (d) PC TeSR-E8, (e) PC mTeSR1, and (f) PC StemMACS iPS-Brew XF were all characterized by particle 
precipitation. Concerning the hiPSC aggregate culture, (g) low protein TeSR-E8 supported the culture when 
static conditioned, but (j) it caused hiPSC disruption when peristaltic pump conditioned. Contrarily, static 
and peristaltic pump conditioning of high protein media supported hiPSC aggregate culture, even if with (h,k) 
hiPSC aggregates more heterogeneous in size in case of mTeSR1, and (i,l) elevated amount of particles in case of 
StemMACS iPS-Brew XF. Scale bar = 100 µm.
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in the medium. These complex fluid mechanics phenomena, in combination with a constant interaction of the 
medium with the hydrophobic surface of the tubing, could stress insulin. Subsequently, self-association of insulin 
into amorphous insoluble particles is fostered depleting soluble insulin.
Definitive strategies for dissolved insulin stabilization have not been established35. However, several stabi-
lizing additives have been described including: ionic and non-ionic surfactants53, 54, glycerol42, 43, albumin47, 71, 
α-crystallin35. Furthermore, alternative insulin formulations, including artificial insulin analogues, have been 
proposed43, 45, 48.
In this study, three different strategies to avoid dissolved insulin depletion from E8 were followed. Firstly, 
the addition of glycerol: the compound did not affect hiPSC aggregate culture (Fig. 5g) but could not overcome 
insulin precipitation neither rescue hPSC viability in case of peristaltic pump conditioning (Fig. 5d and j). 
Secondly, an artificial insulin analogue, Aspart, was tested. Developed for continuous subcutaneous insulin infu-
sion pumps44, Aspart is characterized by reduced tendency of molecular self-association compared to human 
insulin45. While E8 supplemented with Aspart fully supported hiPSC aggregate culture in controls (Fig. 5h), its 
precipitation induced by peristaltic pumping was not avoided (Fig. 5e,k).
Lastly, albumin supplementation, which has been extensively used as stabilizing excipient in several thera-
peutic protein formulations46, 56, was tested. Although micro-particles were detectable in PC E8 + HSA (Fig. 5f, 
Suppl. Fig. S7c,d) and HSA itself may precipitate as well35, 0.1% HSA did preserve insulin under peristaltic pump 
conditioning (Fig. 6) and efficiently supported hPSC propagation (Figs 5l and 7l for hiPSCs, Figs 5n and 7t for 
hESCs) without affecting pluripotency maintenance (Fig. 7ae and am for hiPSCs, Fig. 7ah and ap for hESCs). 
Mechanistically, HSA may (1) counteract the adsorption of insulin to the tubing surface33–35, and/or (2) stabilize 
insulin by acting as a molecular chaperone preventing the misfolding and/or aggregation into precipitated par-
ticles47, 71.
In this study non-recombinant HSA was adopted. However, in order to develop clinically-compliant culture 
conditions for future applications, recombinant human serum albumin (rHSA) should be considered to guaran-
tee high level of purity and to avoid batch variability and possible contamination by viruses or prions46, 72.
Pump-based circuits are broadly applied in biotechnology. This includes their use in automated monitoring 
devices73 as well as for specific bioprocessing methods and cell culture bioreactors9, 27, 74–76. This study demon-
strates how the application of such established technology may result in unexpected, previously overlooked issues, 
when applied in a closely related field. The presented findings put the spot on the important aspects of hPSC 
cultivation in low-protein media, which is generally favored for the production of Advanced Therapy Medicinal 
Products (ATMPs), such as hPSC-derived progenies.
In the perspective of developing chemically defined culture media and establishing novel strategies for auto-
mated propagation of hPSCs, the inherent physical instability of insulin may become a substantial hurdle. In more 
general terms, the study highlights the importance of closely monitoring culture media components in frame of 
the applied culture strategy. While this is already applied in process development of conventional mammalian 
mass cell culture77, this topic has been hardly attended in the field of hPSC cultivation and differentiation.
Methods
Materials. hPSC culture media: self-made chemically defined E817, (Supplementary Table S9); TeSR-E8 
(STEMCELL Technologies, Vancouver, Canada); mTeSR1 (STEMCELL Technologies, Vancouver, Canada); 
StemMACS iPS-Brew XF (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany). Further culture media: Gibco 
DMEM/F12 (Thermo Fisher Scientific Inc., MA, USA); self-made E8 lacking one protein at a time (i.e. E8 minus 
-bFGF, -TGFβ1, -transferrin, -insulin); self-made E8 supplemented with 1, 5, or 10 g/L of glycerol (Sigma-Aldrich, 
Munich, Germany); E8 containing 20 mg/mL insulin analogue Aspart (Novorapid, Novo Nordisk A/S, Bagsvaerd, 
Denmark) for replacement of conventional human insulin; E8 supplemented with 0.01%, 0.1%, or 1% of HSA 
(Biological Industries, Beit-Haemek, Israel). Cell culture: Geltrex (Thermo Fisher Scientific Inc., MA, USA); self-
made Rho-associated coiled-coil kinase inhibitor Y27632 (RI)78. Flow cytometry: propidium iodide (PI) (BD 
Biosciences, Franklin Lakes, NJ, USA), NANOG (Cell Signaling Technology, Danvers, MA, USA), OCT4 (Santa 
Cruz Biotechnology, Santa Cruz, CA, USA), Cy-3 conjugated Donkey anti-Rabbit and Cy-5 conjugated Donkey 
anti-Mouse (Jackson ImmunoResearch Inc., West Grove, PA, USA). Tubing: Biopharm Plus Platinum-cured 
Silicone (Masterflex, Cole-Parmer, IL, USA); Tygon E-LFL (Masterflex, Cole-Parmer, IL, USA).
Culture media conditioning. The hPSC media were conditioned overnight in the incubator (37 °C, 5% 
CO2) under (Fig. 1b): (1) static conditioning in 50 mL tube (SC); (2) continuous circulation within a closed-loop 
peristaltic pump-based circuit (PC). The PC circuit was composed of a medium reservoir, oxygen-permeable 
platinum-cured silicone tubing with quick-disconnect couplings, and a peristaltic pump (Masterflex L/S Tubing 
Pump, Cole-Parmer, IL, USA), for a total working volume of approximately 50 mL. Within the PC circuit, the 
culture media were conditioned imposing flow rates of 5, 50 and 100 ml/min. In addition, culture medium E8 
was tested using two different tubing formulations (Biopharm Plus Platinum-cured Silicone and Tygon E-LFL) 
and conditioned under continuous circulation within a chandler loop system (CC, Fig. 1b). In the CC set-up, the 
continuous circulation of the medium was obtained with a closed loop tubing imposing a rotational velocity set 
to maintain the same PC flow rate.
hPSC aggregate culture. Biological experiments were performed using the hiPSC line 
hHSC_1285_T-iPS279, obtained from our laboratory upon request and derived from peripheral blood donated 
by healthy volunteers following informed consent, and the hESC line HES3 NKX2-5eGFP/w80, available from 
Dr. Elliott (Murdoch Childrens Research Institute). Ahead of process inoculation, hPSCs were expanded in 
feeder-free monolayer culture on Geltrex-coated flasks in E8 for at least 4 passages as described in detail else-
where26. Pre-cultures for the tests did not exceed 8 passages in feeder-free monolayer culture.
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In order to obtain hPSC aggregates, single cells were cultured in 3 mL E8 supplemented with the RI (10 µM) 
small molecule within 6-well suspension culture plates (1x106 cells/well, d-1) positioned on an orbital shaker (70 
revolution per minute = rpm) for 24 h inside the incubator5. hPSC aggregates were harvested (d0) and cultured 
with conditioned media in 6-well suspension culture plates positioned on an orbital shaker (70 rpm) for further 
72 h (Fig. 1a). No media changes were performed after d0 and for the 3 days of culture. All tests were performed 
in three independent runs. hPSCs were used in accordance with the Hannover Medical School Ethics Committee 
and are covered by appropriate consent that permits their use in the proposed research. All procedures were per-
formed in accordance with the applicable ethical and legal regulations.
Light microscopy. Light microscopy images were recorded (1) right after the conditioning for media inspec-
tion, and (2) daily for monitoring the hPSC aggregates (Axio Vert.A1 microscope and Axiovision 8.4 software, 
Zeiss, Thornwood, NY).
Flow cytometry. Flow cytometry analyses for characterizing cell death (PI) at day 1 and day 3, and cell 
pluripotency (NANOG, OCT4) at day 3 have been performed. hPSC aggregates were harvested, washed with 
PBS and dissociated into single cells with Accutase. Following cell count 2x105 single cells were stained with PI 
according to manufacturer’s instructions. NANOG and OCT4 staining were performed as follow: 2x105 single 
cells were fixed with 90% methanol for 15 min on ice, then washed thoroughly and primary antibody added for 
one hour at room temperature according to manufacturer’s dilution. Following a washing step, secondary anti-
bodies were added (Cy-3 conjugated Donkey anti-Rabbit for NANOG, Cy-5 conjugated Donkey anti-Mouse for 
OCT4) according to manufacturer’s dilution and incubated at room temperature for one hour in the dark. Buffer 
used for antibody addition was composed of PBS with 0.5% BSA, 3 mM EDTA and 0.1% Triton X-100. Samples 
suspended in PBS with 0.5% BSA and 3 mM EDTA were then assessed with the BD Accuri C6 Flow Cytometer, 
gates were set according to respective isotype controls.
UPLC-MS analysis. UPLC-MS analyses were performed on the conditioned media to provide a 
semi-quantitative measure of the remaining concentration of insulin. Each sample was separated by UPLC 
(Waters Acquity UPLC; column Waters Acquity HSS T3 1.8 µm, 2.1 × 100 mm; solvent A = water, 0.1% formic 
acid; solvent B = acetonitil, 0.1% formic acid; solvent gradient: 0 min (98% A), 2 min (98% A), 9 min (50% A), 
12 min (0% A), 13 min (0% A), 13.10 min (98% A), run time 15 min; injection volume 5 mL, flow rate = 400 µL/
min) and analysed by ESI-MS (Waters Q-Tof premier, positive mode, capillary voltage = 3 kV). The insulin con-
tent was determined by recording and integrating the intensity of the most intensive multiple charged positive 
ions for insulin (4,5,6-time charged ions 968.8, 1162.4, and 1452.1, respectively; n = 2).
Data availability. The datasets generated and/or analyzed during the current study are available from the 
corresponding author on reasonable request.
See Supplementary Information for details about scanning electron microscope analysis of the tubing lumen 
and characterizations of the PC E8 precipitated particles and of the agglomerates attached to the tubing lumen.
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